BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Analysis

BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future

The Asia-Pacific (APAC) region is rapidly emerging as a global powerhouse in the biopharmaceutical industry. This growth is fueled by a combination of inno...

December 20, 2024 | Analysis

IPO Renaissance: Biopharma's Strategic Momentum Sets the Stage for 2025

The IPO class of 2024 has redefined the biopharma and life sciences landscape, marking a return to growth after a prolonged period of market caution. These...

November 27, 2024 | Report

Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts

In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...

October 17, 2024 | Interview

Cervical Cancer Screenings Drop Among Commercially Insured Women, Analysis Reveals Alarming Decline in Lifesaving Tests

The number of women getting recommended cervical cancer screenings is declining, according to data from Cedar Gate Technologies’ proprietary Nat...

January 18, 2024 | Analysis

Biotech and Biopharma Industry Trends: What to Watch for in 2024

In a year-round up preview, Dr. Senthil Sockalingam, Head of IQVIA Biotech in Japan-Asia Pacific and Chief Medical Officer of IQVIA Asia Pacific, offers a ...

December 18, 2023 | Opinion | By Dr Senthil Sockalingam, Head, IQVIA Biotech in Japan-Asia Pacific; Chief Medical Officer, IQVIA Asia Pacific

BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears

To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervi...

July 24, 2023 | News

Cytiva launches 2023 Biopharma Resilience Index

Industry leaders rate capabilities in five key areas: supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government poli...

June 20, 2023 | Analysis

Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results

Highlights: Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up 9.5% on a core(1) basis. GAAP net income of $302...

May 24, 2023 | News

Pfizer urges awareness of life-threatening ATTR-CM disease

ATTR-CM is caused by unstable transthyretin proteins that misfold and aggregate into amyloid fibrils that build up in the heart and other parts of the body...

May 12, 2023 | Analysis

The Impact of Digital Health Technologies in Oncology: Current State and Future Directions

Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...

May 03, 2023 | Opinion

BGI Global's Colorectal Cancer Survey uncovers gaps in awareness and concerns over affordability

This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...

April 07, 2023 | News

Australia Diabetes Market Projected to Reach $5.96 Billion by 2028, Reports Research and Markets

Research and Markets, a leading market research company, has released a report on the Australia Diabetes Market projecting it to reach ...

April 02, 2023 | News

The Rapidly Growing Biopharma Industry in Southeast Asia: Which Countries are Leading the Way?

Singapore: A Biopharma Hub Singapore is one of the most prominent players in the Southeast Asian biopharma industry. It has positioned itself as a hub for...

March 31, 2023 | News

Genscript Biotech Reports 2022 Annual Results

Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, representing an increase of 27.7% as compare...

March 31, 2023 | Company results

Stay Connected